The creator is doubling down on HIMS at $41, believing it's the best time to buy due to historical support and a favorable risk-to-reward ratio, despite a recent 14% drop.
Source Post
Full official play on $HIMS, it is still a phenomenal buy at $41. “$HIMS $48 playing the range, playing for...
Nov 10, 2025
The creator discusses HIMS & Hers Health, Inc. (HIMS), highlighting a previous buy recommendation at $41 and a subsequent drop to that level. Despite the dip, the creator expresses conviction in the stock, citing chart patterns and historical support levels, and has doubled down on their position by buying more shares at $45 and $41. They outline a trading strategy with a stop-loss and target, emphasizing the favorable risk-to-reward ratio at current levels.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
HIMSbuy opened Nov 10, 2025
-43.92%